spacer
home > white papers > The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology - European Society for Medical Oncology (ESMO)
WHITE PAPERS
logo_European_S6.jpg

European Society for Medical Oncology (ESMO)

phone +41 (0)91 973 19 00
email esmo@esmo.org
web http://www.esmo.org

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology

 

The number of cancer patients in Europe is rising and significant advances in basic and applied cancer research are making the provision of optimal care more challenging. The concept of cancer as a systemic, highly heterogeneous and complex disease has increased the awareness that quality cancer care should be provided by a multidisciplinary team (MDT) of highly qualified healthcare professionals. Cancer patients also have the right to benefit from medical progress by receiving optimal treatment from adequately trained and highly skilled medical professionals. Built on the highest standards of professional training and continuing medical education, medical oncology is recognised as an independent medical specialty in many European countries.

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

BioIVT to Host Webinar Describing In Vitro Models to Predict Herb-Drug Interactions

BioIVT, a leading provider of biospecimens and related services, today announced that it will be hosting a webinar entitled “Whole-cell In Vitro Models Can Predict Clinically-relevant Herb-Drug Interactions (HDIs)” at 11 am ET on June 20.
More info >>


White Papers

Systems Engineering for Complex Portable Medical Device Development

Phillips-Medisize

As the demand for complex, portable medical devices continues to grow, reducing risk and increasing efficiency during the development of these products should be paramount. Taking a systems-engineering (SE) approach to development provides a holistic, organized, and deliberate method for identifying as well as reducing both patient and business risks early in the process. Furthermore, it facilitates efficient progression throughout the entire product development life cycle.
More info >>


Industry Events

SMi presents the 13th Conference on ADMET

9-10 July 2018, Holiday Inn Kensington Forum, London, UK

SMi is delighted to announce the 13th annual ADMET conference returning to London to explore the optimisation of ADMET modelling techniques, preclinical DMPK applications and development of biopharmaceuticals.
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement